Pfizer wins cancer drug patent case against AstraZeneca
The US District Court for the District of Delaware has ordered AstraZeneca to pay $107.5m to Pfizer in damages for infringing patents related to the lung cancer drug Tagrisso. The patents in question are licensed by Pfizer to Puma Biotechnology for the …